CTT PHARMACEUTICAL HOLDINGS, INC. purchased $187 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,400 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-09-28.
How this was made
The 30-second read
Why it matters
The filing provides a primary source of insider activity but the monetary value is minimal.
Market read
Limited relevance; only micro‑cap investors may note the insider buy.
What to watch
Potential upcoming corporate actions or financing needs not disclosed in the filing.
Background
SEC Form 4 filing discloses insider transactions; required for transparency.
Ticker impact
CEO purchased 3,400 shares at $0.0550 each, increasing his stake to 9,429,956 shares.
possible slight positive pressure as market absorbs the news
The transaction amount ($187) is trivial relative to market cap; any price effect will be minimal.
Market effects
None; the purchase does not affect the broader pharmaceutical sector.
None; limited to the micro‑cap's trading community.
None
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a confidence signal.
Key entities
- companyCTT Pharmaceutical Holdings, Inc.
Issuer of the Form 4 filing.
- personCEO (unnamed)
Insider executing the purchase.